Microbiome therapeutics
Description
Development of a novel two-step process for the production of next Generation microbiome therapeutics. We will develop an innovative, two step production technology for consortia of strict anaerobic gut bacteria. This will be the first GMP grade, large scale production process in the gut microbiome field, resulting in viable, highly efficient and stable microbial products.
Key Data
Projectlead
Prof. Dr. Dieter Eibl, Dr. Florian Rosenthal
Deputy Projectlead
Project team
Project partners
PharmaBiome AG
Project status
completed, 05/2018 - 12/2020
Funding partner
Innovationsprojekt / Projekt Nr. 27873.1 PFLS-LS
Project budget
19'665 CHF